Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India

Open Access

Peer-reviewed

Research Article

Petros Isaakidis ,

* E-mail: msfocb-asia-epidemio@brussels.msf.org

Affiliation Médecins Sans Frontières, Mumbai, India
⨯
Roma Paryani,

Affiliation Médecins Sans Frontières, Mumbai, India
⨯
Samsuddin Khan,

Affiliation Médecins Sans Frontières, Mumbai, India
⨯
Homa Mansoor,

Affiliation Médecins Sans Frontières, Mumbai, India
⨯
Mamta Manglani,

Affiliation Pediatric Centre of Excellence for HIV Care, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India
⨯
Asmaa Valiyakath,

Affiliation Médecins Sans Frontières, Mumbai, India
⨯
Peter Saranchuk,

Affiliation Southern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa
⨯
Jennifer Furin

Affiliation Tuberculosis Research Unit, Case Western Reserve University, Cleveland, Ohio, United States of America
⨯

Reader Comments (0)

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Adolescents
Is the Subject Area "Adolescents" applicable to this article?

Thanks for your feedback.
Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Pediatrics
Is the Subject Area "Pediatrics" applicable to this article?

Thanks for your feedback.